Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright ...
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) was upgraded by equities research analysts at Scotiabank from a “sector perform” rating to a “sector outperform” rating in a report released on Monday ...
When Best Buy launches its new U.S. marketplace this summer, it won't just be expanding its product assortment—it'll be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results